CD9 and glioblastoma: In this instance, elevated TNC+ EV levels remained statistically significant in glioblastoma patientswhen compared to HD, particularly in the case of TNC+/CD9+ EVs (FC = 12.05, p < 0.01) (Figure 4C,D).